XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 170.06%40.18M | ---- | 0.58%-57.35M | ---- | 18.00%-57.69M | ---- | -65.43%-70.35M | ---- | -72.65%-42.53M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -1,300.00%-14K | ---- | ---1K | ---- | ---- | ---- | ---- | ---- | 33.33%-2K |
Attributable subsidiary (profit) loss | ---- | -157.41%-31K | ---- | --54K | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | ---- | -145.10%-18.31M | ---- | -44.43%40.6M | ---- | -16.99%73.07M | ---- | 1,096.89%88.03M | ---- | 744.43%7.36M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | --1.89M | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | -3.42%282K | ---- | -14.12%292K | ---- | -16.87%340K | ---- | 8.49%409K | ---- | --377K |
-Other impairments and provisions | ---- | -146.13%-18.6M | ---- | -43.10%40.31M | ---- | -19.15%70.84M | ---- | 1,155.69%87.62M | ---- | 701.15%6.98M |
Revaluation surplus: | ---- | -59.19%6.81M | ---- | 199.62%16.7M | ---- | -65.23%-16.76M | ---- | -166.09%-10.14M | ---- | 0.83%15.35M |
-Other fair value changes | ---- | -59.19%6.81M | ---- | 199.62%16.7M | ---- | -65.23%-16.76M | ---- | -166.09%-10.14M | ---- | 0.83%15.35M |
Asset sale loss (gain): | ---- | ---29.25M | ---- | ---- | ---- | ---- | ---- | --49K | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---29.25M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --49K | ---- | ---- |
Depreciation and amortization: | ---- | -50.00%113K | ---- | -85.61%226K | ---- | 6,184.00%1.57M | ---- | -64.79%25K | ---- | -79.89%71K |
Financial expense | ---- | -38.70%179K | ---- | -37.87%292K | ---- | 150.00%470K | ---- | -28.24%188K | ---- | 208.24%262K |
Special items | ---- | ---113K | ---- | ---- | ---- | 13.74%2.79M | ---- | -85.60%2.45M | ---- | 4,064.06%17.03M |
Operating profit before the change of operating capital | ---- | -184.30%-435K | ---- | -85.07%516K | ---- | -66.28%3.46M | ---- | 516.62%10.25M | ---- | 68.01%-2.46M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 110.47%498K | ---- | ---4.76M | ---- | ---- | ---- | ---- | ---- | ---- |
Accounts receivable (increase)decrease | ---- | 500.10%34.9M | ---- | 58.72%-8.72M | ---- | -426.89%-21.13M | ---- | 1.13%6.46M | ---- | 66.37%6.39M |
Accounts payable increase (decrease) | ---- | -395.87%-26.7M | ---- | -64.81%9.02M | ---- | 294.47%25.64M | ---- | 67.76%-13.19M | ---- | -197.93%-40.9M |
Financial assets at fair value (increase)decrease | ---- | -130.48%-10.11M | ---- | 53.71%-4.39M | ---- | 14.07%-9.48M | ---- | -26,995.12%-11.03M | ---- | 100.07%41K |
Special items for working capital changes | ---- | 93.48%-1.23M | ---- | 6.47%-18.8M | ---- | -25.27%-20.1M | ---- | -371.12%-16.05M | ---- | 397.84%5.92M |
Cash from business operations | ---- | 88.68%-3.07M | ---- | -25.55%-27.13M | ---- | 8.22%-21.61M | ---- | 24.08%-23.54M | ---- | -60.26%-31.01M |
Other taxs | ---- | --4K | ---- | ---- | ---- | -347.62%-156K | ---- | 105.72%63K | ---- | -4,338.46%-1.1M |
Interest paid - operating | ---- | 38.70%-179K | ---- | 37.87%-292K | ---- | -150.00%-470K | ---- | 28.24%-188K | ---- | -208.24%-262K |
Special items of business | -120.79%-1.43M | ---- | 138.42%6.87M | ---- | -143.52%-17.87M | ---- | -48.13%-7.34M | ---- | 69.08%-4.95M | ---- |
Net cash from operations | -120.79%-1.43M | 88.16%-3.25M | 138.42%6.87M | -23.33%-27.42M | -143.52%-17.87M | 6.06%-22.23M | -48.13%-7.34M | 26.89%-23.67M | 69.08%-4.95M | -66.80%-32.37M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 1,300.00%14K | ---- | --1K | ---- | ---- | ---- | ---- | ---- | -33.33%2K |
Purchase of fixed assets | ---- | ---- | ---- | ---- | ---- | ---2.31M | ---- | ---- | ---- | ---- |
Sale of subsidiaries | ---- | ---68K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---133K | ---- | ---- | ---- | ---- | ---- | ---- |
Other items in the investment business | 60.00%8K | ---- | --5K | ---- | ---- | ---- | ---2.31M | ---- | ---- | ---- |
Net cash from investment operations | 60.00%8K | 59.09%-54K | --5K | 94.30%-132K | ---- | ---2.31M | ---2.31M | ---- | ---- | 166.67%2K |
Net cash before financing | -120.66%-1.42M | 88.03%-3.3M | 138.45%6.87M | -12.24%-27.55M | -85.13%-17.87M | -3.72%-24.55M | -94.85%-9.65M | 26.89%-23.67M | 69.08%-4.95M | -66.77%-32.37M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.8M | ---- | ---- |
Refund | ---- | -6.59%-776K | ---- | -7.22%-728K | ---- | -71.03%-679K | ---- | 43.12%-397K | ---- | -6.40%-698K |
Issuing shares | ---- | ---- | ---- | -93.87%3.56M | ---- | 323.58%58M | ---- | --13.69M | ---- | ---- |
Other items of the financing business | 6.37%-940K | ---- | -138.48%-1M | ---- | 561.77%2.61M | ---- | 56.20%-565K | ---- | -206.35%-1.29M | -200.00%-973K |
Net cash from financing operations | 6.37%-940K | -233.07%-2.03M | -138.48%-1M | -97.27%1.52M | 561.77%2.61M | 269.48%55.81M | 56.20%-565K | 498.10%15.1M | -206.35%-1.29M | -1,296.85%-3.79M |
Effect of rate | ---- | ---- | ---- | ---1K | ---- | ---- | ---- | 100.99%2K | 98.21%-1K | -307.14%-203K |
Net Cash | -140.21%-2.36M | 79.53%-5.33M | 138.45%5.87M | -183.26%-26.03M | -49.35%-15.26M | 465.14%31.26M | -63.64%-10.22M | 76.33%-8.56M | 57.83%-6.24M | -89.41%-36.16M |
Begining period cash | -19.84%21.52M | -49.22%26.85M | -49.22%26.85M | 144.62%52.88M | 144.62%52.88M | -28.37%21.62M | -28.37%21.62M | -54.65%30.17M | -54.65%30.17M | -22.21%66.54M |
Cash at the end | -41.43%19.16M | -19.84%21.52M | -13.03%32.71M | -49.22%26.85M | 230.00%37.62M | 144.62%52.88M | -52.37%11.4M | -28.37%21.62M | -53.69%23.93M | -54.65%30.17M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.